Abstract
Background: Genetic and environmental risk factors are assumed to contribute to the susceptibility to cervical artery dissection (CeAD). To explore the role of genetic imbalance in the etiology of CeAD, copy number variants (CNVs) were identified in high-density microarrays samples from the multicenter CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) study and from control subjects from the CADISP study and the German PopGen biobank. Microarray data from 833 CeAD patients and 2040 control subjects (565 subjects with ischemic stroke due to causes different from CeAD and 1475 disease-free individuals) were analyzed. Rare genic CNVs were equally frequent in CeAD-patients (16.4%; n=137) and in control subjects (17.0%; n=346) but differed with respect to their genetic content. Compared to control subjects, CNVs from CeAD patients were enriched for genes associated with muscle organ development and cell differentiation, which suggests a possible association with arterial development. CNVs affecting cardiovascular system development were more common in CeAD patients than in control subjects (p=0.003; odds ratio (OR) =2.5; 95% confidence interval (95% CI) =1.4-4.5) and more common in patients with a familial history of CeAD than in those with sporadic CeAD (p=0.036; OR=11.2; 95% CI=1.2-107).
Conclusion: The findings suggest that rare genetic imbalance affecting cardiovascular system development may contribute to the risk of CeAD. Validation of these findings in independent study populations is warranted.Keywords: Copy number variation, Cervical artery dissection, Rare genetic variation, Cardiovascular system development.
Current Genomics
Title:Genetic Imbalance in Patients with Cervical Artery Dissection
Volume: 18 Issue: 2
Author(s): Antti J. Metso, for the CADISP group, Stefan T. Engelter, Philippe A. Lyrer, Didier Leys, Turgut Tatlisumak, Elisabetta Del Zotto, Emmanuel Touze, Vincent Thijs, Stefan Schreiber, Christopher Traenka, Alessandro Pezzini, Christoph Lichy, Manja Kloss, Armin J. Grau, Tiina M. Metso, Caspar Grond-Ginsbach, Juan-Jose Martin, Giacomo Giacalone, Andreas Geschwendtner, Martin Dichgans, Stephanie Debette, Valeria Caso, Tobias Brandt, Anna Bersano, Marie-Luise Arnold, Sherine Abboud, Yanxiang Jiang, Philip Ginsbach, Rastislav Pjontek, Michael Krawczak and Bowang Chen
Affiliation:
Keywords: Copy number variation, Cervical artery dissection, Rare genetic variation, Cardiovascular system development.
Abstract: Background: Genetic and environmental risk factors are assumed to contribute to the susceptibility to cervical artery dissection (CeAD). To explore the role of genetic imbalance in the etiology of CeAD, copy number variants (CNVs) were identified in high-density microarrays samples from the multicenter CADISP (Cervical Artery Dissection and Ischemic Stroke Patients) study and from control subjects from the CADISP study and the German PopGen biobank. Microarray data from 833 CeAD patients and 2040 control subjects (565 subjects with ischemic stroke due to causes different from CeAD and 1475 disease-free individuals) were analyzed. Rare genic CNVs were equally frequent in CeAD-patients (16.4%; n=137) and in control subjects (17.0%; n=346) but differed with respect to their genetic content. Compared to control subjects, CNVs from CeAD patients were enriched for genes associated with muscle organ development and cell differentiation, which suggests a possible association with arterial development. CNVs affecting cardiovascular system development were more common in CeAD patients than in control subjects (p=0.003; odds ratio (OR) =2.5; 95% confidence interval (95% CI) =1.4-4.5) and more common in patients with a familial history of CeAD than in those with sporadic CeAD (p=0.036; OR=11.2; 95% CI=1.2-107).
Conclusion: The findings suggest that rare genetic imbalance affecting cardiovascular system development may contribute to the risk of CeAD. Validation of these findings in independent study populations is warranted.Export Options
About this article
Cite this article as:
Metso J. Antti, for the CADISP group , Engelter T. Stefan, Lyrer A. Philippe, Leys Didier, Tatlisumak Turgut, Zotto Del Elisabetta, Touze Emmanuel, Thijs Vincent, Schreiber Stefan, Traenka Christopher, Pezzini Alessandro, Lichy Christoph, Kloss Manja, Grau J. Armin, Metso M. Tiina, Grond-Ginsbach Caspar, Martin Juan-Jose, Giacalone Giacomo, Geschwendtner Andreas, Dichgans Martin, Debette Stephanie, Caso Valeria, Brandt Tobias, Bersano Anna, Arnold Marie-Luise, Abboud Sherine, Jiang Yanxiang, Ginsbach Philip, Pjontek Rastislav, Krawczak Michael and Chen Bowang, Genetic Imbalance in Patients with Cervical Artery Dissection, Current Genomics 2017; 18 (2) . https://dx.doi.org/10.2174/1389202917666160805152627
DOI https://dx.doi.org/10.2174/1389202917666160805152627 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Obstetrical Hemorrhage Review
Current Women`s Health Reviews Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Current Pharmaceutical Biotechnology Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Angiotensin II Regulates Vascular and Endothelial Dysfunction: Recent Topics of Angiotensin II Type-1 Receptor Signaling in the Vasculature
Current Vascular Pharmacology Depression and Vascular Disease: Conceptual Issues, Relationships and Clinical Implications
Vascular Disease Prevention (Discontinued) Cardiovascular Disease in Patients with Diabetic Nephropathy
Current Molecular Medicine MicroRNAs as Potential Therapeutic Agents in the Treatment of Myocardial Infarction
Current Vascular Pharmacology Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets
Current Drug Targets Current Strategies to Achieve Further Cardiac and Renal Protection through Enhanced Renin-Angiotensin-Aldosterone System Inhibition
Reviews on Recent Clinical Trials Human Clinical Studies of Tea Polyphenols in Allergy or Life Style-related Diseases
Current Pharmaceutical Design Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews Cerebrovascular Amyloidosis and Dementia
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine The Effects of Exercise on Postpartum Weight Retention in Overweight and Obese Women
Current Women`s Health Reviews Coronary Artery Disease and End-Stage Renal Disease - A Clinical Perspective
Current Hypertension Reviews Specificities of the Diabetic Population in French Guiana: The Health Barometer Survey
Current Diabetes Reviews Bioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Current Pharmaceutical Design Is Hypertension an Inflammatory Process?
Current Pharmaceutical Design